Lnc-SNHG5通过RPS3-NFκB途径促进了肝细胞癌的进展
Jie Hao1,2,3, Yu Liu1, Fengli Guo1,4
1Department of Thyroid and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, People's Republic of China.
长非编码RNA SNHG5通过调节RPS3-NFκB通路促进肝细胞癌 (HCC) 的进展. 升级的lnc-SNHG5可以作为HCC的诊断标志物和治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 肝细胞癌 (HCC) 是一种普遍存在的恶性瘤,具有复杂的分子基础.
- 识别新的分子机制和生物标志物对于改善HCC诊断和治疗至关重要.
- 长非编码RNAs (lncRNAs) 越来越多地被认为是它们在癌症发展中的作用.
研究的目的:
- 研究lnc-SNHG5和RPS3在肝细胞癌中的作用和机制.
- 探索Inc-SNHG5作为HCC的潜在生物标志物和治疗点的临床意义.
主要方法:
- 在HCC组织和细胞系中使用TCGA,TIMER,UALCAN和RT-qPCR对lnc-SNHG5和RPS3的表达分析.
- 功能性检测包括殖民地形成,CCK8和流细胞计,以评估细胞增殖和细胞亡.
- 西部斑点分析检查RPS3和NFκB通路蛋白水平.
- 使用皮下瘤模型进行体内研究以验证研究结果.
主要成果:
- 在HCC组织和细胞中,Lnc-SNHG5表达显著升高.
- 上调的lnc-SNHG5增强了细胞活力和增殖,同时影响了细胞亡.
- 发现Lnc-SNHG5与RPS3相互作用,并调节NFκB信号通路.
- 在体内实验证实了lnc-SNHG5在HCC进展中的致癌作用.
结论:
- 通过调节RPS3-NFκB通路,Lnc-SNHG5是HCC恶性表型的关键驱动因素.
- Lnc-SNHG5是一个有前途的诊断标记物和肝细胞癌的治疗点.
- 向lnc-SNHG5可能为HCC分子向治疗提供了一种新的策略.
更多相关视频
05:45In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System
Published on: January 9, 2020
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
相关概念视频
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Abnormal Proliferation
lncRNA - Long Non-coding RNAs
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Ras Gene
Ras is a...
